YURVAC® RHD is a recombinant vaccine indicated for active immunisation of rabbits from 30 days of age onwards to reduce mortality of rabbit haemorrhagic disease (RHD) caused by classical RHD virus (RHDV) and variant strains (RHDV2), including highly virulent strains.
YURVAC® RHD vaccine against RHDV and RHDV2
Publications
Rabbits
The aim of this study was to demonstrate the efficacy of YURVAC® RHD against different strains of RHD
Download this article
Related products
Recombinant vaccine against rabbit haemorrhagic disease (RHD) caused by the classical (RHDV) and variant (RHDV2) strains, including highly virulent strains, in an emulsion for injection.
Inactivated vaccine against the variant strain of rabbit haemorrhagic disease (RHDV-2), in injectable emulsion.
Inactivated vaccine against the variant strain of rabbit haemorrhagic disease (RHDV-2), in injectable emulsion.
Live heterologous vaccine against myxomatosis, in injectable freeze-dried tablet.
Live homologous vaccine against myxomatosis, in injectable freeze-dried tablet
Inactivated vaccine against the classic strain of rabbit haemorrhagic disease (RHDV1), in injectable emulsion
Enrofloxacin, in oral solution, animal medicine, animal medicines, medicine for rabbits, rabbit medicine, medicine for poultry
Vitamins A, D3 and E, in injectable solution
Related services
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Access an advanced diagnostic service with maximum comfort and reliability
